Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Kidney Injury | 2 | 2026 | 700 | 1.020 |
Why?
|
| Ribonucleotides | 1 | 2024 | 31 | 0.850 |
Why?
|
| RNA Stability | 1 | 2024 | 75 | 0.830 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2024 | 186 | 0.810 |
Why?
|
| Child, Hospitalized | 1 | 2023 | 76 | 0.730 |
Why?
|
| Aneuploidy | 2 | 2019 | 136 | 0.570 |
Why?
|
| Probiotics | 1 | 2021 | 226 | 0.560 |
Why?
|
| Hypertension | 1 | 2026 | 1352 | 0.530 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2026 | 848 | 0.520 |
Why?
|
| Telomerase | 2 | 2015 | 153 | 0.520 |
Why?
|
| Urinary Tract Infections | 1 | 2021 | 335 | 0.490 |
Why?
|
| Breast Neoplasms | 2 | 2024 | 2597 | 0.430 |
Why?
|
| Telomere | 1 | 2015 | 218 | 0.390 |
Why?
|
| Triple Negative Breast Neoplasms | 3 | 2025 | 279 | 0.340 |
Why?
|
| Incidence | 2 | 2026 | 3321 | 0.250 |
Why?
|
| Cell Line, Tumor | 6 | 2025 | 3713 | 0.240 |
Why?
|
| Proteinuria | 1 | 2026 | 108 | 0.230 |
Why?
|
| Health Priorities | 1 | 2025 | 42 | 0.230 |
Why?
|
| Mitosis | 1 | 2025 | 191 | 0.220 |
Why?
|
| Collagen Type IV | 1 | 2024 | 20 | 0.220 |
Why?
|
| Nephritis, Hereditary | 1 | 2024 | 21 | 0.220 |
Why?
|
| Proteogenomics | 1 | 2025 | 111 | 0.210 |
Why?
|
| Lipid Peroxidation | 2 | 2024 | 92 | 0.200 |
Why?
|
| Research | 1 | 2025 | 264 | 0.200 |
Why?
|
| Income | 1 | 2023 | 137 | 0.180 |
Why?
|
| Child | 6 | 2026 | 26168 | 0.180 |
Why?
|
| Mice | 8 | 2025 | 18160 | 0.170 |
Why?
|
| Spliceosomes | 1 | 2021 | 47 | 0.160 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2021 | 117 | 0.160 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2020 | 18 | 0.160 |
Why?
|
| Immunity | 1 | 2021 | 178 | 0.150 |
Why?
|
| Neoplasms | 2 | 2025 | 2977 | 0.150 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2019 | 37 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2024 | 2008 | 0.150 |
Why?
|
| Humans | 15 | 2026 | 130075 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2025 | 558 | 0.150 |
Why?
|
| Kidney | 3 | 2024 | 1279 | 0.150 |
Why?
|
| Reperfusion Injury | 1 | 2020 | 107 | 0.150 |
Why?
|
| Nephrosis | 1 | 2018 | 6 | 0.140 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 168 | 0.140 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 378 | 0.140 |
Why?
|
| Hernia, Hiatal | 1 | 2018 | 55 | 0.140 |
Why?
|
| Lymphoma, B-Cell | 1 | 2019 | 145 | 0.140 |
Why?
|
| GTP-Binding Proteins | 1 | 2018 | 156 | 0.130 |
Why?
|
| Animals | 8 | 2025 | 33660 | 0.130 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 534 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 1262 | 0.120 |
Why?
|
| Microcephaly | 1 | 2018 | 347 | 0.110 |
Why?
|
| RNA Polymerase I | 1 | 2014 | 6 | 0.110 |
Why?
|
| DNA, Ribosomal | 1 | 2014 | 49 | 0.110 |
Why?
|
| India | 2 | 2025 | 231 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3782 | 0.100 |
Why?
|
| Cellular Senescence | 1 | 2015 | 216 | 0.100 |
Why?
|
| DNA Replication | 1 | 2015 | 355 | 0.090 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2024 | 67 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 720 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2015 | 542 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 1363 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 2574 | 0.070 |
Why?
|
| Mutation | 2 | 2024 | 6067 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2014 | 2462 | 0.060 |
Why?
|
| Female | 5 | 2025 | 70240 | 0.060 |
Why?
|
| Fibroblasts | 2 | 2020 | 850 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 2330 | 0.060 |
Why?
|
| Nephrotic Syndrome | 1 | 2024 | 53 | 0.050 |
Why?
|
| Autoantigens | 1 | 2024 | 97 | 0.050 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2024 | 3 | 0.050 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2024 | 59 | 0.050 |
Why?
|
| Fluorouracil | 1 | 2024 | 129 | 0.050 |
Why?
|
| Lipid Droplets | 1 | 2024 | 51 | 0.050 |
Why?
|
| Genes, myc | 1 | 2021 | 96 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2024 | 566 | 0.040 |
Why?
|
| Triglycerides | 1 | 2024 | 603 | 0.040 |
Why?
|
| Biopsy | 1 | 2024 | 1240 | 0.040 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 56 | 0.040 |
Why?
|
| Cell Death | 1 | 2021 | 226 | 0.040 |
Why?
|
| Adenosine | 1 | 2021 | 117 | 0.040 |
Why?
|
| Adult | 1 | 2021 | 31012 | 0.040 |
Why?
|
| Cyclohexylamines | 1 | 2020 | 6 | 0.040 |
Why?
|
| Gene Amplification | 1 | 2021 | 219 | 0.040 |
Why?
|
| A549 Cells | 1 | 2020 | 48 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2021 | 248 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 100 | 0.040 |
Why?
|
| Phenylenediamines | 1 | 2020 | 29 | 0.040 |
Why?
|
| Introns | 1 | 2021 | 279 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 699 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 106 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 254 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 208 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2021 | 236 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2024 | 889 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2021 | 570 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 383 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 1001 | 0.030 |
Why?
|
| Piperazines | 1 | 2020 | 267 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 404 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2021 | 4645 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2020 | 256 | 0.030 |
Why?
|
| Genes, Recessive | 1 | 2018 | 193 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2020 | 355 | 0.030 |
Why?
|
| Iron | 1 | 2020 | 305 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 588 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2020 | 454 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2020 | 1570 | 0.030 |
Why?
|
| Glucose | 1 | 2020 | 851 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2020 | 803 | 0.030 |
Why?
|
| Phenotype | 1 | 2024 | 4456 | 0.030 |
Why?
|
| Liver Regeneration | 1 | 2014 | 39 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1826 | 0.030 |
Why?
|
| Myofibroblasts | 1 | 2014 | 62 | 0.030 |
Why?
|
| Rabbits | 1 | 2014 | 572 | 0.020 |
Why?
|
| Adolescent | 2 | 2024 | 20796 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 2322 | 0.020 |
Why?
|
| Protein Binding | 1 | 2014 | 1649 | 0.020 |
Why?
|
| United States | 1 | 2025 | 11893 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 2554 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 612 | 0.020 |
Why?
|
| Liver | 1 | 2014 | 1783 | 0.020 |
Why?
|
| Lung | 1 | 2014 | 1531 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2024 | 17538 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 4691 | 0.010 |
Why?
|
| Male | 2 | 2024 | 64382 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 15002 | 0.010 |
Why?
|